Product Categories
| Country: | China |
|---|---|
| Tel: | 21-61263452 |
| Mobile: | 13641803416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Company Name: | Shanghai GL Peptide Ltd |
| Tel: | 86-21-61263385 |
| Fax: | 86-21-61263399 |
| Email: | ymbetter@glbiochem |
| WebSite: | http://www.glbiochem.com |
| Nationality: | CHINA |
| Product Name | MF | CAS | Details |
|---|
| GP120-W61D-72-S;NFMDNTKTIIV | C57H94N14O18S | Details |
| GP120-W61D-73;NTKTIIVQLNESVAI | C72H127N19O24 | Details |
| GP120-W61D-74-S;LNESVAINCTR | C49H86N16O18S | Details |
| GP120-W61D-75;LNESVAINCTRPNNN | C66H111N23O25S | Details |
| GP120-W61D-78;NNNTRKGIHIGPGRA | C66H113N27O20 | Details |
| GP120-W61D-79;RKGIHIGPGRAFYAA | C74H116N24O17 | Details |
| GP120-W61D-8;AAEQLWVTVYYGVPV | C82H119N17O22 | Details |
| GP120-W61D-82;YAARKIIGDIRQAHC | C74H123N25O20S | Details |
| GP120-W61D-83;KIIGDIRQAHCNLSR | C72H126N26O21S | Details |
| GP120-W61D-84;DIRQAHCNLSRAQWN | C75H118N28O23S | Details |
| GP120-W61D-85;AHCNLSRAQWNNTLK | C74H118N26O22S | Details |
| GP120-W61D-86;LSRAQWNNTLKQIVI | C80H134N24O22 | Details |
| GP120-W61D-88;TLKQIVIKLREHFGN | C82H138N24O21 | Details |
| GP120-W61D-89;IVIKLREHFGNKTIK | C83H142N24O20 | Details |
| HIV-1 MN ENV-9;LWVTVYYGVPVWKEA | C91H128N18O21 | Details |
| HATPPKKKRK, 5-TMR labeled;5-TMR-HATPPKKKRK | C82H119ClN22O18 | Details |
| hBD-1, β-Defensin-1, human;DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK(Disulfidebridge:5-34,12-27,17-35) | Details |
| hBD-3, β-Defensin-3, human;GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK(Disulfidebridge:11-40,18-33,23-41) | Details |
| hBD-4, β-Defensin-4, human;ELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRK(Disulfidebridge:6-33:13-27:17-34) | Details |
| HBVpol455? HBV polymerase (455-463);GLSRYVARL | Details |
| HCV (Hepatitis C Virus) NS3/4A Protease Substrate;Ac-DE-Dap(QXL520)-EE-Abu-ψ-[COO]AS-C(5-FAMsp)-NH2 | Details |
| HCV Core Protein (1-20)??;MSTNPKPQRKTKRNTNRRPQ | Details |
| HCV NS3/4A Protease Substrate Hydrolysis Product 1;Ac-DE-Dap(QXL520)-EE-Abu | Details |
| HCV NS3/4A Protease Substrate Hydrolysis Product 2;Lac-Ser-Cys(5-FAMsp)-NH2 | Details |
| HCV Protease Substrate (RET S1);Ac-DE-D(Edans)-EE-Abu-ψ-[COO]-AS-K(Dabcyl)-NH2 | Details |
| HCV, NS4A-Like Peptide??;KKGSVVIVGRIVLSGKPAIIPKK | Details |
| H-D-Val-Leu-Lys-AFC;vLK-AFC | C27H38F3N5O5 | 97055-77-1 | Details |
| Hemoglobin, 2837a, Malaria FRET substrate III??;DABCYL-GABA-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-EDANS | Details |
| Hemoglobin, 3037a, Malaria FRET Substrate II??;DABCYL-GABA-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-EDANS | Details |
| Hepatitis Virus C NS3 Protease Inhibitor 2;Ac-DE-Dif-E-Cha-C | C43H56N6O14S | Details |
| Hepatitis Virus C NS3 Protease Inhibitor 3;Ac-DE-Dif-I-Cha-C | C44H60N6O12S | Details |
| Hepatitis Virus C NS3 Protease Inhibitor 4;Ac-DELE-Cha-C | C34H54N6O14S | Details |
| HER2/Neu Substrate;AAEEIYAARRG | C51H83N17O17 | Details |
| H-Glu-Ala-Ala-Phe-AFC;EAAF-AFC | C30H32F3N5O8 | Details |
| H-Gly-Pro-AMC;GP-AMC | C17H19N3O4 | Details |
| HIF-1 {alpha} (556-574)??;DLDLEMLAPYIPMDDDFQL | C101H152N20O34S2 | 1201633-99-9 | Details |
| HIF-2 (66-84)??;SLEAQGIKADRETVAVKPT | Details |
| Growth Hormone Releasing Factor, GRF (1-44), amide, bovine;YADAIFTNSYRKVLGQLSARKLLQDIMNRQQGERNQEQGAKVRL-NH2 | Details |
| Growth Hormone Releasing Factor, GRF (1-44), amide, porcine;YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGERNQEQGARVRL-NH2 | Details |
| Growth Hormone Releasing Factor, GRF, (1-40), human;YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGA | Details |
| GSK-3 Substrate, Biotinylated, Phosphorylated;Biotin-RRAAEELDSRAG-pS-PQL | C86H143N29O29S | Details |
| GSK-3 Substrate, Biotinylated;Biotin-RRAAEELDSRAGSPQL | C81H136N28O28S | Details |
| GST-Sa Chimera-Catalyzed Peptide;EAIYAAPFAK | C52H77N11O14 | Details |
| Gycogen Synthase-derived peptide, phosphorylated, TAMRA-labeled??;5-TAMRA-KKLNRTL-pS-VA-OH | Details |
| Gycogen Synthase-derived peptide, phosphorylated??;KKLNRTL-pS-VA-OH | Details |
| H-Ala-Arg-Arg-AFC;ARR-AFC | C25H35F3N10O5 | Details |
| H-Ala-Leu-Lys-AMC;ALK-AMC | C25H37N5O5 | Details |
| H-Ala-Phe(4-fluoro)-Arg-Cha-homoArg-Tyr-NH2; | C43H66FN13O7 | Details |
| HATPPKKKRK, 5-FAM labeled;5-FAM-HATPPKKKRK | C74H105N19O18 | Details |
| HIV Protease FRET Substrate I;DABCYL-GABA-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS | C73H97N17O18S | 127134-13-8 | Details |
| HIV Protein Reverse Transcriptase Peptide (RT33-41);ALVEICTEM | C42H73N9O15S2 | Details |
| HIV-1 CONSENSUS B VIF-1;MENRWQVMIVWQVDR | C88H136N26O23S2 | Details |
| HIV-1 CONSENSUS B VIF-11;RHHYESTHPRISSEV | C78H119N27O25 | Details |
| HIV-1 CONSENSUS B VIF-12;ESTHPRISSEVHIPL | C74H120N22O24 | Details |
| Histone deacetylase, HDAC substrate??;Ac-RGK(Ac)-AMC | Details |
| Histone H1-derived peptide, FAM-labeled??;5-FAM-GGGPATPKKAKKL-OH | Details |
| Histone H1-derived peptide, phosphorylated??;GGGPA-pT-PKKAKKL-OH | Details |
| Histone H1-derived peptide, TAMRA labeled??;5-TAMRA-GGGPATPKKAKKL-OH | Details |
| Histone H3 (1-21), Biotinylated??;ARTKQTARKSTGGKAPRKQLA-GG-K(BIOTIN)-NH2 | Details |
| Histone H3 (1-21), N-Terminal??;ARTKQTARKSTGGKAPRKQLA | Details |
| HIV gag p24 peptide (197-205); | Details |
| HIV-1 MN #1990;SKLKEQFKNKTIVFNQSSGG | C99H162N28O31 | Details |
| GP120-W61D-91;FGNKTIKFNQSSGGD | C69H106N20O24 | Details |
| GP120-W61D-95;EIVRHSFNCGGEFFY | C83H113N21O23S | Details |
| GP120-W61D-97;CGGEFFYCDTTQLFN | C78H105N17O25S2 | Details |
| GP120-W61D-97-S;FFYCDTTQLFN | C66H87N13O19S | Details |
| GP120-W61D-98;FFYCDTTQLFNSTWN | C88H115N19O26S | Details |
| GP120-W61D-98-S;DTTQLFNSTWN | C58H83N15O21 | Details |
| GPHRSTPESRAAV, 5-TMR labeled;5-TMR-GPHRSTPESRAAV | C85H117ClN24O25 | Details |
| GPHRSTPESRAAV, Biotinylated;Biotin-GPHRSTPESRAAV | C66H107N23O21S | Details |
| GR231118;H-Ile-Glu-Pro-Dap-Tyr-Arg-Leu-Arg-Tyr-NH2 | C110H170N34O24 | 158859-98-4 | Details |
| GP120-W61D-87;QWNNTLKQIVIKLRE | C85H143N25O23 | Details |
| GP120-W61D-72;NFMDNTKTIIVQLNE | C77H126N20O26S | Details |
| GP120-W61D-71;IRSDNFMDNTKTIIV | C76H127N21O25S | Details |
| GRGDS, amide;GRGDS-NH2 | C17H31N9O8 | 143648-02-6 | Details |
| HIV-1 CONSENSUS B VIF-10;GWFYRHHYESTHPRI | C93H124N28O22 | Details |
| GSK3 Substrate, a, b subunit;RAAVPPSPSLSRHSSPHQSEDEEE | C108H169N35O42 | Details |
| GP120-W61D-76;VAINCTRPNNNTRKG | C66H116N26O22S | Details |
| GPHRSTPESRAAV, 5-FAM labeled;5-FAM-GPHRSTPESRAAV | C77H103N21O25 | Details |
| GP120-W61D-99;DTTQLFNSTWNGTEG | C80H117N21O33 | Details |
| GP120-W61D-96;HSFNCGGEFFYCDTT | C76H98N18O25S2 | Details |
| GP120-W61D-94;GGDPEIVRHSFNCGG | C64H97N21O22S | Details |
| GP120-W61D-92;TIKFNQSSGGDPEIV | C69H110N18O25 | Details |
| HIV-1 MN #1957;PKISFEPIPIHYCAPAGFAI | C105H155N23O25S | Details |
| HIV-1 CONSENSUS B VIF-15;IPLGDAKLVITTYWG | C79H123N17O21 | Details |
| HIV-1 CONSENSUS B VIF-13;PRISSEVHIPLGDAK | C71H119N21O22 | Details |
| HA-pT-PPKKKRK, Phosphorylated;HA-pT-PPKKKRK | C53H96N19O15P | Details |
| H-Ala-Phe(4-fluoro)-Arg-Cha-homoArg-Tyr(3-iodo)-NH2; | C43H65FIN13O7 | Details |
| H-D-Val-Leu-Arg-AFC;vLR-AFC | C27H38F3N7O5 | Details |
| GP120-W61D-81;GRAFYAARKIIGDIR | C77H127N25O19 | Details |
| GP120-W61D-80;HIGPGRAFYAARKII | C78H124N24O17 | Details |
| GP120-W61D-77;CTRPNNNTRKGIHIG | C68H117N27O21S | Details |
| GP120-W61D-74;IIVQLNESVAINCTR | C71H125N21O23S | Details |
| GP120-W61D-93;NQSSGGDPEIVRHSF | C68H104N22O25 | Details |
| HATPPKKKRK;HATPPKKKRK | C53H95N19O12 | Details |
| HATPPKKKRK, Biotinylated;Biotin-HATPPKKKRK | C63H109N21O14S | Details |
| GP120-W61D-90;LREHFGNKTIKFNQS | C81H127N25O23 | Details |
| HIV-1 CONSENSUS B VIF-14;SEVHIPLGDAKLVIT | C72H122N18O22 | Details |
| H-D-Phe-Pro-Arg-AFC;fPR-AFC | C30H34F3N7O5 | Details |
| Growth Hormone Releasing Factor, GRF (1-44), amide, human;YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 | Details |
| Product Total： Product Page： | ||||
| 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||